LAG3 and neoplasm: High relative levels of tumour-targeting effector T cells and the naïve (LAG-3+) helper T population protected patients from metastatic progression, with the proportion of LAG-3+ cells inversely correlating with the serum content of antagonising pro-inflammatory damaged mtDNA.